Not logged in.png)
Share.png)
SaveMiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells
Veys, Clement; Boulouard, Flavie; Benmoussa, Abderrahim; Jammes, Manon; Brotin, Emilie; Redini, Francoise; Poulain, Laurent; Gruchy, Nicolas; Denoyelle, Christophe; Legendre, Florence; Galera, Philippe Share Save Share Save Enhanced chondrogenesis of bone marrow-derived stem cells by using a combinatory cell therapy strategy with BMP-2/TGF-β1, hypoxia, and COL1A1/HtrA1 siRNAsLegendre, Florence; Ollitrault, David; Gomez-Leduc, Tangni; Bouyoucef, Mouloud; Hervieu, Magalie; Gruchy, Nicolas; Mallein-Gerin, Frederic; Leclercq, Sylvain; Demoor, Magali; Galera, Philippe Share Save Chondrogenic commitment of human umbilical cord blood-derived mesenchymal stem cells in collagen matrices for cartilage engineeringGomez-Leduc, Tangni; Hervieu, Magalie; Legendre, Florence; Bouyoucef, Mouloud; Gruchy, Nicolas; Poulain, Laurent; de Vienne, Claire; Herlicoviez, Michel; Demoor, Magali; Galera, Philippe Share Save Share Save Share Save CHARACTERIZATION AND USE OF EQUINE BONE MARROW MESENCHYMAL STEM CELLS IN HORSE CARTILAGE ENGINEERINGBranly, T.; Hervieu, M.; Jacquet, S.; Bertoni, L.; Gomez-Leduc, T.; Desance, M.; Rakic, R.; Bouyoucef, M.; Audigie, F.; Legendre, F.; Demoor, M.; Denoix, J-M.; Galera, P. Share Save Share Save REDIFFERENTIATION OF HUMAN DEDIFFERENTIATED CHONDROCYTES : AN INNOVATIVE COMBINATION FOR THE CELL THERAPY OF ARTICULAR CARTILAGELegendre, F.; Ollitrault, D.; Hervieu, M.; Bauge, C.; Maneix, L.; Benateau, H.; Renard, E.; Leclercq, S.; Chajra, H.; Drougard, C.; Briand, M.; Poulain, L.; Mallein-Gerin, F.; Boumediene, K.; Galera, P.; Demoor, M. Share Save SNORC, A NEW SPECIFIC MARKER OF HUMAN DIFFERENTIATED ARTICULAR CHONDROCYTESOllitrault, D., Jr.; Legendre, F., Jr.; Gomez-Leduc, T., Jr.; Bigot, N., Jr.; Leclercq, S., Sr.; Bauge, C., Jr.; Boumediene, K., Sr.; Demoor, M., Sr.; Galera, P., Sr. Share Save Deciphering signaling mechanisms controling chondrocyte differentiation: Application to tissue engineering of cartilage: The ANR-TecSan PROMOCART projectClaus, S.; Aubert-Foucher, E.; Perrier-Groult, E.; Bougault, C.; Ronziere, M. -C.; Freyria, A. -M.; Legendre, F.; Ollitrault, D.; Boumediene, K.; Demoor, M.; Galera, P.; Tian, T. V.; Flajollet, S.; Duterque-Coquillaud, M.; Damour, O.; Chajra, H.; Mallein-Gerin, F. Share Save BMP-2, HYPOXIA, COLLAGEN SPONGES AND PARTICULAR INHIBITORS: AN INNOVATIVE COMBINATION FOR THE RECOVERY OF HUMAN CHONDROCYTE PHENOTYPE. APPLICATIONS FOR THE CELL THERAPY OF ARTICULAR CARTILAGEOllitrault, D.; Legendre, F.; Hervieu, M.; Bauge, C.; Maneix, L.; Renard, E.; Goux, D.; Leclercq, S.; Chajra, H.; Mallein-Gerin, F.; Boumediene, K.; Demoor, M.; Galera, P. Share Save Share Save Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular Chondrocytes requires a decrease of Sp1•Sp3 ratio and of the binding activity of both factors to the COL2A1 promoterPoree, Benoit; Kypriotou, Magdalini; Chadjichristos, Christos; Beauchef, Gallic; Renard, Emmanuelle; Legendre, Florence; Melin, Martine; Gueret, Sylviane; Hartmann, Daniel-Jean; Mallein-Gerin, Frederic; Pujol, Jean-Pierre; Boumediene, Karim; Galera, Philippe Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
